FDA Adverse Event Malfunction Summary report: N

FINELINE II

MDR report key: 2905447 · Received January 9, 2013

Report

Report Number
2124215-2012-14134
Event Type
Malfunction
Date Received
January 9, 2013
Date of Event
October 2, 2012
Report Date
June 20, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
PMA / PMN Number
P960004
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

THE PHYSICIAN WILL CONTINUE TO MONITOR THE LEAD. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST-MARKET QUALITY ASSURANCE LABORATORY, A THOROUGH EVALUATION OF THE LEAD WAS PERFORMED. VISUAL OBSERVATION NOTED THAT THE STYLET WSA RETURNED IN THE LEAD LUMEN, THE CONDUCTOR COILS WERE DEFORMED 175 AND 239 MILLIMETERS (MM) FROM THE TERMINAL PIN, A CUT WAS NOTED IN THE LEAD INSULATION AT 239 MM FROM THE TERMINAL PIN FROM REMOVAL OF THE SUTURE SLEEVE TIE DOWN AND THE HELIX WAS BENT. RESISTANCE TESTING AND A PRESSURE TEST OF THE INNER INSULATION WAS COMPLETED TO ASSESS LEAD ELECTRICAL PERFORMANCE AND INSULATION INTEGRITY. MEASUREMENTS THROUGHOUT THESE TESTS WERE WITHIN NORMAL LIMITS. ANALYSIS WAS UNABLE TO CONFIRM THE REPORTED CLINICAL OBSERVATIONS.

Additional Manufacturer Narrative · 1

THE PRODUCT HAS BEEN RECEIVED FOR ANALYSIS. THIS REPORT WILL BE UPDATED UPON COMPLETION OF ANALYSIS.

Description of Event or Problem · 1

--

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT PACING IMPEDANCE MEASUREMENTS FOR THIS RIGHT ATRIAL (RA) LEAD INCREASED FROM THE 350-400 OHM RANGE TO 500 OHMS. IT WAS REPORTED THAT THE LEAD APPEARED LOWER THAN THE RIGHT VENTRICULAR (RV) LEAD ON LATERAL X-RAY IMAGING. AN RA LEAD DISLODGEMENT WAS SUSPECTED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 1

ADDITIONAL INFORMATION WAS RECEIVED THAT AN INVASIVE PROCEDURE WAS PERFORMED APPROXIMATELY SEVEN MONTHS LATER. UPON OPENING THE POCKET, A SUTURE WAS OBSERVED ON THE LEAD AND ONE ON THE SUTURE SLEEVE. THE LEAD WAS EXPLANTED AND REPLACED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
10589 FINELINE II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4469

Patients

Seq Age Sex Outcome Treatment
1 86 YR 4136| 4469| K063